BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 28095869)

  • 1. Macrophage Activation Syndrome: different mechanisms leading to a one clinical syndrome.
    Bracaglia C; Prencipe G; De Benedetti F
    Pediatr Rheumatol Online J; 2017 Jan; 15(1):5. PubMed ID: 28095869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Bracaglia C; de Graaf K; Pires Marafon D; Guilhot F; Ferlin W; Prencipe G; Caiello I; Davì S; Schulert G; Ravelli A; Grom AA; de Min C; De Benedetti F
    Ann Rheum Dis; 2017 Jan; 76(1):166-172. PubMed ID: 27296321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.
    Put K; Avau A; Brisse E; Mitera T; Put S; Proost P; Bader-Meunier B; Westhovens R; Van den Eynde BJ; Orabona C; Fallarino F; De Somer L; Tousseyn T; Quartier P; Wouters C; Matthys P
    Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
    Arduini A; Marasco E; Marucci G; Pardeo M; Insalaco A; Caiello I; Moneta GM; Prencipe G; De Benedetti F; Bracaglia C
    Pediatr Rheumatol Online J; 2019 May; 17(1):25. PubMed ID: 31118063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocytes From Patients With Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis Are Hyperresponsive to Interferon Gamma.
    Pascarella A; Bracaglia C; Caiello I; Arduini A; Moneta GM; Rossi MN; Matteo V; Pardeo M; De Benedetti F; Prencipe G
    Front Immunol; 2021; 12():663329. PubMed ID: 33815425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice.
    Behrens EM; Canna SW; Slade K; Rao S; Kreiger PA; Paessler M; Kambayashi T; Koretzky GA
    J Clin Invest; 2011 Jun; 121(6):2264-77. PubMed ID: 21576823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment.
    Ravelli A; Grom AA; Behrens EM; Cron RQ
    Genes Immun; 2012 Jun; 13(4):289-98. PubMed ID: 22418018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis.
    Put K; Brisse E; Avau A; Imbrechts M; Mitera T; Janssens R; Proost P; Fallarino F; Wouters CH; Matthys P
    PLoS One; 2016; 11(2):e0150075. PubMed ID: 26914138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage activation syndrome in the era of biologic therapy.
    Grom AA; Horne A; De Benedetti F
    Nat Rev Rheumatol; 2016 May; 12(5):259-68. PubMed ID: 27009539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage activation syndrome and cytokine-directed therapies.
    Schulert GS; Grom AA
    Best Pract Res Clin Rheumatol; 2014 Apr; 28(2):277-92. PubMed ID: 24974063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities.
    Naveen R; Jain A; Muhammed H; Gupta L; Misra DP; Lawrence A; Agarwal V; Misra R; Aggarwal A
    Rheumatol Int; 2021 Mar; 41(3):625-631. PubMed ID: 33388903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.
    Vandenhaute J; Wouters CH; Matthys P
    Front Immunol; 2019; 10():3089. PubMed ID: 32010140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetics of the Anti-Interferon-Gamma Monoclonal Antibody Emapalumab: An Updated Analysis.
    Brossard P; Laveille C
    Rheumatol Ther; 2024 Jun; 11(3):869-880. PubMed ID: 38662147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reaching the threshold: a multilayer pathogenesis of macrophage activation syndrome.
    Strippoli R; Caiello I; De Benedetti F
    J Rheumatol; 2013 Jun; 40(6):761-7. PubMed ID: 23588947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine balance and cytokine-driven natural killer cell dysfunction in systemic juvenile idiopathic arthritis.
    Avau A; Put K; Wouters CH; Matthys P
    Cytokine Growth Factor Rev; 2015 Feb; 26(1):35-45. PubMed ID: 24948570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of interferon-gamma levels may lead to earlier diagnosing macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Lu M; Teng L; Xu Y; Xu X
    Pediatr Rheumatol Online J; 2023 Oct; 21(1):115. PubMed ID: 37828529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Moderately Dosed Etoposide in Macrophage Activation Syndrome-Hemophagocytic Lymphohistiocytosis.
    Horne A; von Bahr Greenwood T; Chiang SCC; Meeths M; Björklund C; Ekelund M; Erensjö P; Berg S; Hagelberg S; Bryceson YT; Andersson U; Henter JI
    J Rheumatol; 2021 Oct; 48(10):1596-1602. PubMed ID: 33589555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous anakinra for the treatment of haemophagocytic lymphohistiocytosis/macrophage activation syndrome: A systematic review.
    Charlesworth JEG; Kavirayani A
    Eur J Haematol; 2023 Sep; 111(3):458-476. PubMed ID: 37344166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Shimizu M; Mizuta M; Okamoto N; Yasumi T; Iwata N; Umebayashi H; Okura Y; Kinjo N; Kubota T; Nakagishi Y; Nishimura K; Mohri M; Yashiro M; Yasumura J; Wakiguchi H; Mori M
    Pediatr Rheumatol Online J; 2020 Jan; 18(1):2. PubMed ID: 31924225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte and bone marrow macrophage transcriptional phenotypes in systemic juvenile idiopathic arthritis reveal TRIM8 as a mediator of IFN-γ hyper-responsiveness and risk for macrophage activation syndrome.
    Schulert GS; Pickering AV; Do T; Dhakal S; Fall N; Schnell D; Medvedovic M; Salomonis N; Thornton S; Grom AA
    Ann Rheum Dis; 2021 May; 80(5):617-625. PubMed ID: 33277241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.